Le Lézard
Classified in: Health
Subject: v

Extendicare Announces April 2024 Dividend of C$0.04 per Share


MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors' population. We operate a network of 125 long-term care homes (53 owned/72 under management contracts), deliver 10 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 136,200 beds across Canada. Extendicare proudly employs approximately 22,000 qualified, highly trained and dedicated team members who are passionate about providing high-quality care and services to help people live better.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions "anticipate", "believe", "estimate", "expect", "intend", "objective", "plan", "project", "will", "may", "should" or other similar expressions or the negative thereof. These forward-looking statements reflect the Company's current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare's website at www.extendicare.com

Extendicare contact:

Jillian E. Fountain
Vice President, Investor Relations
T: (905) 470-5534
E: [email protected] 
www.extendicare.com 



These press releases may also interest you

at 15:47
The American Pharmacists Association (APhA) released cybersecurity recommendations today for urgent policy changes to better secure the pharmacy ecosystem and patient safety. The recommendations were submitted as Statements for the Record to the...

at 15:45
Today, Spinal Simplicity is pleased to announce the Food and Drug Administration (FDA)...

at 15:31
Phoenix Children's today unveiled a 407-foot commissioned mural that has transformed a heavily trafficked corridor into a captivating and exciting journey for children and their families. Nearly two years in the making, the art installation, called...

at 15:30
Roland DGA's DGSHAPE Americas dental business group has announced the addition of the 3DX Dental 3D printer Bundle, Powered by Roland DGA to its line of dental products and accessories. This bundle offers a reliable, full-service 3D printing solution...

at 15:17
Biolexis Therapeutics, Inc. a clinical-stage AI-driven biopharmaceutical company, today announced it will present a late-breaking poster at the 2024 American Association of Immunologists (AAI), taking place May 3-7, 2024, in Chicago, IL....

at 15:16
AdventHealth Ocala and AdventHealth Carrollwood, along with all AdventHealth hospitals in Pasco County, including AdventHealth Wesley Chapel, AdventHealth Dade City and AdventHealth Zephyrhills, have once again earned an "A" Hospital Safety Grade...



News published on and distributed by: